We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
-4.85%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$46.6B
AUM Growth
-$4.41B
(-8.6%)
Cap. Flow
-$915M
Cap. Flow
% of AUM
-1.97%
Top 10 Holdings %
Top 10 Hldgs %
31.78%
Holding
2,365
New
27
Increased
297
Reduced
1,868
Closed
169
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown & Brown
BRO
|
+$161M |
| 2 |
Church & Dwight Co
CHD
|
+$150M |
| 3 |
Advanced Micro Devices
AMD
|
+$78.9M |
| 4 |
Old Dominion Freight Line
ODFL
|
+$56.9M |
| 5 |
AstraZeneca
AZN
|
+$53.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$170M |
| 2 |
AT&T
T
|
+$142M |
| 3 |
Microsoft
MSFT
|
+$136M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$110M |
| 5 |
Amazon
AMZN
|
+$86.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.53% |
| 2 | Consumer Discretionary | 13.24% |
| 3 | Communication Services | 9.89% |
| 4 | Healthcare | 9.39% |
| 5 | Consumer Staples | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
SIGA Technologies
SIGA
$223M
| $118K | ﹤0.01% |
16,717
-4,263
| -20% | -$28.5K |
|
2002
Organogenesis Holdings
ORGO
$308M
| $117K | ﹤0.01% |
15,211
+4,905
| +48% | +$38K |
|
|
VVNT
2003
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $116K | ﹤0.01% |
17,181
-2,833
| -14% | -$20.2K |
|
2004
Douglas Elliman
DOUG
$155M
| $115K | ﹤0.01% |
16,551
-2,477
| -13% | -$18.8K |
|
|
VXRT
2005
DELISTED
Vaxart
VXRT
| $115K | ﹤0.01% |
22,951
-3,785
| -14% | -$19.2K |
|
2006
IDEAYA Biosciences
IDYA
$3.41B
| $114K | ﹤0.01% |
10,125
-2,451
| -19% | -$36.1K |
|
2007
Ocugen
OCGN
$410M
| $114K | ﹤0.01% |
34,651
-5,693
| -14% | -$20K |
|
2008
Praxis Precision Medicines
PRAX
$9.07B
| $112K | ﹤0.01% |
730
-176
| -19% | -$36.2K |
|
2009
Ocular Therapeutix
OCUL
$1.86B
| $111K | ﹤0.01% |
22,316
-5,216
| -19% | -$28.9K |
|
|
GOEV
2010
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $110K | ﹤0.01% |
43
-8
| -16% | -$22K |
|
|
VRAY
2011
DELISTED
ViewRay, Inc.
VRAY
| $110K | ﹤0.01% |
28,218
-2,024
| -7% | -$8.62K |
|
2012
Immunovant
IMVT
$8.09B
| $108K | ﹤0.01% |
19,654
-5,301
| -21% | -$33K |
|
2013
OraSure Technologies
OSUR
$273M
| $108K | ﹤0.01% |
15,926
-1,966
| -11% | -$15.7K |
|
2014
Ouster
OUST
$2.29B
| $108K | ﹤0.01% |
2,392
-1,036
| -30% | -$38.2K |
|
|
DBD
2015
DELISTED
Diebold Nixdorf Incorporated
DBD
| $108K | ﹤0.01% |
16,034
-1,973
| -11% | -$16.9K |
|
|
DAWN
2016
DELISTED
Day One Biopharmaceuticals
DAWN
| $106K | ﹤0.01% |
10,675
-452
| -4% | -$5.97K |
|
2017
Omeros
OMER
$709M
| $106K | ﹤0.01% |
17,779
-4,205
| -19% | -$26.2K |
|
|
OSG
2018
Octave Specialty Group
OSG
$252M
| $105K | ﹤0.01% |
10,144
-1,248
| -11% | -$16.9K |
|
2019
Dyne Therapeutics
DYN
$4.04B
| $105K | ﹤0.01% |
10,966
-2,853
| -21% | -$24.3K |
|
2020
Immersion
IMMR
$216M
| $105K | ﹤0.01% |
+18,874
| New | +$97.8K |
|
2021
Sutro Biopharma
STRO
$379M
| $105K | ﹤0.01% |
1,293
-306
| -19% | -$29.1K |
|
|
FMTX
2022
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $105K | ﹤0.01% |
11,275
-2,823
| -20% | -$30K |
|
2023
Fossil Group
FOSL
$239M
| $103K | ﹤0.01% |
10,602
-1,318
| -11% | -$14.9K |
|
|
GBIO
2024
DELISTED
Generation Bio
GBIO
| $103K | ﹤0.01% |
1,412
-344
| -20% | -$19.9K |
|
|
CMRX
2025
DELISTED
Chimerix, Inc.
CMRX
| $103K | ﹤0.01% |
22,685
-5,494
| -19% | -$30.6K |
|
Similar funds
ProShare Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, ProShare Advisors held 2,365 positions worth $46.6B, down 8.6% from $51B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
ProShare Advisors's Q1 2022 filing shows 27 new, 297 increased, 1,868 reduced and 169 closed positions. Its largest new stake was Constellation Energy: 594,655 shares worth $33.4M. The largest sale was Apple, an estimated $170M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- ProShare Advisors's largest Q1 2022 buy was Constellation Energy: 594,655 shares worth $33.4M.
- ProShare Advisors added most to Brown & Brown in Q1 2022, an estimated $161M increase.
- ProShare Advisors's biggest Q1 2022 reduction was Apple, cutting an estimated $170M.
- ProShare Advisors fully exited Xilinx Inc in Q1 2022, selling an estimated $110M.
- ProShare Advisors's ten largest holdings make up 32% of its $46.6B portfolio in Q1 2022.
- ProShare Advisors opened 27 new positions and closed 169 in Q1 2022.
- ProShare Advisors's portfolio value fell 8.6% quarter-over-quarter to $46.6B.
Based on ProShare Advisors's 13F filing for Q1 2022, filed 10 May 2022.